Analysis of Trends in Cancer-related Mortality in Turkey

Analysis of Trends in Cancer-related Mortality in Turkey

OBJECTIVECancer is one of the most important causes of death, both in Turkey and in the world. Cancer also causeseconomic burden to countries. Therefore, it is important to evaluate the data and mortality trends related to cancer using statistical methods to take primary or secondary preventive measures. In this study,we aimed to analyse the recent changes in cancer mortality via using Joinpoint Regression Analysis(JRA) method between 2009 and 2017.METHODSThe data on cancer-related mortality in Turkey from the database of the Turkish Statistical Institute(TurkStat) were obtained and analysed with the JRA method. Age-standardized mortality rate (ASR),annual percent change (APC) and average annual percent change (AAPC) were calculated and compared according to gender.RESULTSIn female patients, the significant increase in mortality trends were observed in breast, gastrointestinal system (liver, pancreas, and colon) and gynecological cancers (ovarian and corpus uteri). In malepatients, liver, pancreas, colon, lip, oral cavity, pharynx and bladder cancers were shown to increasesignificantly. There was no significant increase in other cancer sites.CONCLUSIONTo our knowledge, this study is the first study that has analyzed cancer and cancer-related death trendsusing JRA at the national level in Turkey. We think that our study can demonstrate the contrast trends incancer rates. According to these results, better health interventions could be developed to fight againstcancer and to reduce the incidence of cancer-related morbidity and mortality.

___

  • 1. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends–an update. Cancer Epidemiology and Prevention Biomarkers 2016;25(1):16−27.
  • 2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer, 2013.
  • 3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394−424.
  • 4. TurkStat, Turkish Statistical Institute, Cause of Death Statistics. Available from: www.turkstat.gov.tr.
  • 5. WHO. International statistical classification of disease and related health problems. 10th revision. Volume 2. Geneva; 2008. Available from: https://icd.who. int/browse10/Content/statichtml/ICD10Volume2_ en_2008.pdf.
  • 6. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age Standardization of Rates: a new Who Standard. WHO, 2001. Available from: https://www.who.int/healthinfo/paper31.pdf?ua=1.
  • 7. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19(3):335−51.
  • 8. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med 2009;28(29):3670−82.
  • 9. Kim, HJ, Luo J, Chen HS, Green D, Buckman D, Byrne J, et al. Improved confidence interval for average annual percent change in trend analysis. Stat Med 2017;36(19):3059−74.
  • 10.National Cancer Institute. Joinpoint Regression Program, Version 4.7.0.0. February, 2019. Available from: https://surveillance.cancer.gov/joinpoint/.
  • 11.National Cancer Institute. Joinpoint Help Manual, Version 4.6.0.0. Surveillance Research Program, April 2018. Available from: https://surveillance.cancer.gov/ joinpoint/Joinpoint_Help_4.6.0.0.pdf.
  • 12.World Health Organization. International Agency for Research on Cancer, Latest global cancer data, Press release No:263, Geneva, Switzerland, 2018. Available from: https://www.iarc.fr/wp-content/uploads/2018/09/pr263_E.pdf
  • 13.Wilson LF, Antonsson A, Green AC, Jordan SJ, Kendall BJ, Nagle CM, et al. How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013. Int J Cancer 2018;142(4):691−701.
  • 14.Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer 2018;118(8):1130−41.
  • 15.Turkiye Kanser İstatistikleri. T.C. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu, Ankara, 2015. Available from: https://docplayer.biz.tr/6567493-Turkiyekanser-istatistikleri.html.
Türk Onkoloji Dergisi-Cover
  • ISSN: 1300-7467
  • Başlangıç: 2015
  • Yayıncı: Ali Cangül
Sayıdaki Diğer Makaleler

Hydrogel Spacer may Allow Prostate Re-irradiation even in Patients with Ulcerative Colitis: A Case Report

Patrizia CORNACCHIONE, Valentina LANCELLOTTA, Luca TAGLIAFERRI, Gian Carlo MATTIUCCI, Vincenzo VALENTINI, Mariangela MASSACCESI, Lucia CERVONE, Antonio PIRAS, Sebastiano MENNA, Luigi AZARİO, Maria ANTONIETTA GAMBACORTA

Correlation of HER2/TOP2A Gene Aberrations with RASSF1A/APC Gene Methylation Status in High-Risk Breast Cancer

Oğuz ÇİLİNGİR, Ayşe Feyda NURSAL, Canan BAYDEMİR, Beyhan DURAK ARAS, Sevilhan ARTAN, Evrim ÇİFTCİ, Onur EROĞLU

Analysis of Survival of the Patients with Brain Metastases from Lung Cancer according to Treatment Modalities and Prognostic Indexes

Halil SAĞINÇ, Papatya Bahar BALTALARLI

A Comparison between Breast-Conserving Surgery and Modified Radical Mastectomy Concerning the Female Sexual Function in Breast Cancer Patients under 50 Years of Age

Bekir Hakan BAKKAL, Özlem ELMAS, Güldeniz KARADENİZ ÇAKMAK

Use of miRNA as a Biomarker in Prostate Cancer and New Approaches

Elif Sibel ASLAN, Sefa ÇETİNKAYA

The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group

Shahrokh KHOSHSIRAT, Ali Asghar PEYVANDI, Mahbobeh OROEI, Hassan PEYVANDI, Ali REZAEIFARD

Mucositis-Induced Pain due to Barrier Dysfunction may have a Direct Effect on Nutritional Status and Quality of Life in Head and Neck Cancer Patients Receiving Radiotherapy

Esra AKDENİZ, Beste M. ATASOY, Kıvanç Bektaş KAYHAN, Birsen DEMİREL

A Challenging Issue for both Patients and Physicians: Breaking Bad News in Oncology

Güler BAHADIR, Dilek ANUK

Out of Field Breast Doses as an Undesired Consequence of Cervical Cancer Radiotherapy

Yunus SARALI, Canan KÖKSAL, Uğur AKBAŞ, Makbule TAMBAŞ, Hatice Bilge BECERİR

Comparison of VMAT, Field in Field, Inverse IMRT, and Helical Tomotherapy Planning in Bilateral Synchronous Breast Cancer: A Case Study

Zedef DAĞ, Şilem ERTÜRK, Oğuzhan AYRANCIOĞLU, Fikri KURT, Ayse KUTLUHAN DOĞAN, N. Deniz ARSLAN